Composite SCCmec Element in Single-locus Variant (ST217) of Epidemic MRSA-15 Clone

1. Mendes RE, Deshpande LM, Costello AJ, Farrell DJ. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals. Antimicrob Agents Chemother. 2012;56:4656–61. http://dx.doi.org/10.1128/AAC.00279-12 2. de Almeida LM, Lincopan N, Araújo MR, Mamizuka EM. Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil. J Antimicrob Chemother. 2012;67:768–9. http://dx.doi. org/10.1093/jac/dkr538 3. Liakopoulos A, Spiliopoulou I, Damani A, Kanellopoulou M, Schoina S, Papafragas E, et al. Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J Antimicrob Chemother. 2010;65:1070– 1. http://dx.doi.org/10.1093/jac/dkq065 4. Seixas R, Monteiro V, Carneiro C, Vilela CL, Oliveira M. First report of a linezolid-resistant MRSA (methicillin resistant Staphylococcus aureus) isolated from a dog with a severe bilateral otitis in Portugal. Revista Veterinaria. 2011;22:81–4. 5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100–S21. Wayne (PA): The Institute; 2010. 6. Kehrenberg C, Schwarz S. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother. 2006;50:1156–63. http://dx.doi. org/10.1128/AAC.50.4.1156-1163.2006 7. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, et al. Acquisition of a natural resistance gene renders a clinical strain of methicillinresistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol. 2007;64:1506–14. http://dx.doi. org/10.1111/j.1365-2958.2007.05744.x 8. Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother. 2009;53:5265–74. http://dx.doi.org/10.1128/AAC.00871-09 9. Novais A, Pires J, Ferreira H, Costa L, Montenegro C, Vuotto C, et al. Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob Agents Chemother. 2012;56:3973–6. http://dx.doi.org/10.1128/AAC.00475-12 10. Rolo J, Lencastre H, Miragaia M. Strategies of adaptation of Staphylococcus epidermidis to hospital and community: amplification and diversification of SCCmec. J Antimicrob Chemother. 2012;67:1333–41. http://dx.doi.org/10.1093/jac/dks068